Oncolytics Biotech Stock Alpha and Beta Analysis
| ONCY Stock | USD 0.92 0.03 3.16% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Oncolytics Biotech. It also helps investors analyze the systematic and unsystematic risks associated with investing in Oncolytics Biotech over a specified time horizon. Remember, high Oncolytics Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Oncolytics Biotech's market risk premium analysis include:
Beta 0.64 | Alpha (0.21) | Risk 2.38 | Sharpe Ratio (0.05) | Expected Return (0.12) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Oncolytics |
Oncolytics Biotech Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Oncolytics Biotech market risk premium is the additional return an investor will receive from holding Oncolytics Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Oncolytics Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Oncolytics Biotech's performance over market.| α | -0.21 | β | 0.64 |
Oncolytics Biotech expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Oncolytics Biotech's Buy-and-hold return. Our buy-and-hold chart shows how Oncolytics Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Oncolytics Biotech Market Price Analysis
Market price analysis indicators help investors to evaluate how Oncolytics Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncolytics Biotech shares will generate the highest return on investment. By understating and applying Oncolytics Biotech stock market price indicators, traders can identify Oncolytics Biotech position entry and exit signals to maximize returns.
Oncolytics Biotech Return and Market Media
The median price of Oncolytics Biotech for the period between Mon, Jun 24, 2024 and Sun, Sep 22, 2024 is 1.0 with a coefficient of variation of 3.94. The daily time series for the period is distributed with a sample standard deviation of 0.04, arithmetic mean of 0.99, and mean deviation of 0.03. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Oncolytics Biotech Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program | 06/27/2024 |
2 | Oncolytics Biotech Stock Price Passes Above 200 Day Moving Average of 1.49 - Defense World | 07/17/2024 |
3 | Heres Why Were Watching Oncolytics Biotechs Cash Burn Situation | 07/25/2024 |
4 | Oncolytics Biotech Reports Second Quarter 2024 Financial Results and Operational Highlights | 08/01/2024 |
5 | Oncolytics Biotech to Participate in a Fireside Chat at Canaccord Genuitys 44th Annual Growth Conference | 08/02/2024 |
6 | Oncolytics Biotech Earns Buy Rating from HC Wainwright - Defense World | 08/21/2024 |
7 | Oncolytics Biotech Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study | 09/19/2024 |
About Oncolytics Biotech Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Oncolytics or other stocks. Alpha measures the amount that position in Oncolytics Biotech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Net Debt To EBITDA | 0.93 | 1.57 | Intangibles To Total Assets | 0.0149 | 0.0141 |
Oncolytics Biotech Upcoming Company Events
As portrayed in its financial statements, the presentation of Oncolytics Biotech's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Oncolytics Biotech's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Oncolytics Biotech's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Oncolytics Biotech. Please utilize our Beneish M Score to check the likelihood of Oncolytics Biotech's management manipulating its earnings.
| 1st of March 2024 Upcoming Quarterly Report | View | |
| 3rd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 1st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Oncolytics Biotech
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Oncolytics Stock Analysis
When running Oncolytics Biotech's price analysis, check to measure Oncolytics Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncolytics Biotech is operating at the current time. Most of Oncolytics Biotech's value examination focuses on studying past and present price action to predict the probability of Oncolytics Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncolytics Biotech's price. Additionally, you may evaluate how the addition of Oncolytics Biotech to your portfolios can decrease your overall portfolio volatility.